"Patents as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about exclusive legal rights or privileges applied to inventions, plants, etc.
| Descriptor ID |
D010330
|
| MeSH Number(s) |
I01.880.604.583.458.650 N03.706.535.518.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Patents as Topic".
Below are MeSH descriptors whose meaning is more specific than "Patents as Topic".
This graph shows the total number of publications written about "Patents as Topic" by people in this website by year, and whether "Patents as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2009 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Patents as Topic" by people in Profiles.
-
Afosah DK, Ofori E, Mottamal M, Al-Horani RA. Factor IX(a) inhibitors: an updated patent review (2003-present). Expert Opin Ther Pat. 2022 Apr; 32(4):381-400.
-
Adekiya TA, Kumar P, Kondiah PPD, Pillay V, Choonara YE. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865.
-
Schroeder RL, Tram P, Liu J, Foroozesh M, Sridhar J. Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibiting cytochrome P450 inhibition: a patent evaluation WO2015048311 (A1). Expert Opin Ther Pat. 2016; 26(1):139-47.
-
Ako-Adounvo AM, Nagarwal RC, Oliveira L, Boddu SH, Wang XS, Dey S, Karla PK. Recent patents on ophthalmic nanoformulations and therapeutic implications. Recent Pat Drug Deliv Formul. 2014; 8(3):193-201.
-
Noguchi S, Yamauchi Y, Takizawa H. Novel therapeutic strategies for fibrotic lung disease: a review with a focus on epithelial-mesenchymal transition. Recent Pat Inflamm Allergy Drug Discov. 2014 Jan; 8(1):9-18.
-
Cui X, Boland T, D'Lima DD, Lotz MK. Thermal inkjet printing in tissue engineering and regenerative medicine. Recent Pat Drug Deliv Formul. 2012 Aug; 6(2):149-55.
-
Kimbro K, Parker S. Recent patents in Toll-like receptor pathways and relevance to cancer. Recent Pat Anticancer Drug Discov. 2009 Nov; 4(3):189-95.
-
Flaer PJ, Younis MZ. The Brazilian experiment: HIV drugs for all. J Health Care Finance. 2009; 36(2):90-6.
-
Praetorius NP, Mandal TK. Engineered nanoparticles in cancer therapy. Recent Pat Drug Deliv Formul. 2007; 1(1):37-51.
-
Chougule MB, Padhi BK, Jinturkar KA, Misra A. Development of dry powder inhalers. Recent Pat Drug Deliv Formul. 2007; 1(1):11-21.